Trials / Completed
CompletedNCT00351806
AISTCM-Outcome Measurement of Acute Ischemic Stroke With Traditional Chinese Medicine
AISTCM-The Pathological Pattern Differentiation and Outcome Measurement of Acute Ischemic Stroke Treated With Traditional Chinese Medicine
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 500 (planned)
- Sponsor
- Guangzhou University of Traditional Chinese Medicine · Academic / Other
- Sex
- All
- Age
- 40 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Traditional Chinese Medicine (TCM) is able to improve the outcome of acute ischemic stroke and to observe its safety.
Detailed description
The purpose of this study is to determine whether Traditional Chinese Medicine (TCM) is able to improve the outcome of acute ischemic stroke and safety.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Erigeron breviscapus injection | |
| DRUG | hua tuo zai zao wan (a herbal medicine pill) | |
| DRUG | Compound stroke herbal medicine (8 herbal) |
Timeline
- Start date
- 2005-07-01
- Completion
- 2006-11-01
- First posted
- 2006-07-13
- Last updated
- 2013-08-07
Locations
22 sites across 1 country: China
Source: ClinicalTrials.gov record NCT00351806. Inclusion in this directory is not an endorsement.